Steven Burke

Steven Burke

Chief Tech/Sci/R&D Officer at AKEBIA THERAPEUTICS, INC.

Net worth: 532 856 $ as of 31/08/2026

65 year
Health Technology
Consumer Services

Profile

Dr. Steven K.
Burke
, MD, is a Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. He is on the Board of Directors at SCYNEXIS, Inc., AbFero Pharmaceuticals, Inc. and LeukoSight, Inc. Dr. Burke was previously employed as a Chief Medical Officer & Senior Vice President by Proteon Therapeutics, Inc., a Senior Vice President-Medical & Regulatory Affairs by Genzyme Corp., a Medical Director & VP-Clinical Research by GelTex Pharmaceuticals, Inc., an Associate Director-Clinical Research by Glaxo, Inc., and a Chief Medical Officer by Protara Therapeutics, Inc. He received his undergraduate degree from Harvard College and a doctorate degree from Weill Cornell Medical College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 5,47,098 ( 0.2% ) 502 783 $ 31/08/2026
18/09/2026 5,750 ( 0.06% ) 30 073 $ 31/08/2026

Steven Burke active positions

CompaniesPositionStart
AKEBIA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 17/06/2019
SCYNEXIS, INC. Director/Board Member 18/09/2026
Director/Board Member -

Former positions of Steven Burke

CompaniesPositionEnd
PROTARA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/01/2019
Chief Tech/Sci/R&D Officer 01/01/2001
Founder -
PROTARA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Glaxo, Inc.
Corporate Officer/Principal -
See the detail of Steven Burke's experience

Training of Steven Burke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Glaxo, Inc.

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology